[go: up one dir, main page]

WO2006115456A1 - Synthesis of 1-aminopiperidine - Google Patents

Synthesis of 1-aminopiperidine Download PDF

Info

Publication number
WO2006115456A1
WO2006115456A1 PCT/SE2006/000499 SE2006000499W WO2006115456A1 WO 2006115456 A1 WO2006115456 A1 WO 2006115456A1 SE 2006000499 W SE2006000499 W SE 2006000499W WO 2006115456 A1 WO2006115456 A1 WO 2006115456A1
Authority
WO
WIPO (PCT)
Prior art keywords
piperidine
aqueous
hydroxylamine
aminopiperidine
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/SE2006/000499
Other languages
French (fr)
Inventor
Ba-Vu Nguyen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nobel Chemicals AB
Original Assignee
Cambrex Karlskoga AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambrex Karlskoga AB filed Critical Cambrex Karlskoga AB
Publication of WO2006115456A1 publication Critical patent/WO2006115456A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/28Nitrogen atoms
    • C07D295/30Nitrogen atoms non-acylated

Definitions

  • This invention broadly relates to a method for synthesizing 1-amino piperidine (N-amino ⁇ i ⁇ eridine). By selecting a proper molar ratio of the starting materials and closely regulating the reaction temperature and the method of product isolation, a high product conversion has been achieved.
  • German Patent 338608 describes reacting piperidine (P) with hydroxylamine-0-sulfonic (HOS) acid in an aqueous alkaline solution (potassium hydroxide) at a mole ratio of P:HOS of about 1.5:1.
  • the HOS was added at a temperature of about 50-70 0 C over a period of about 30 minutes. Thereafter, the reaction mixture was heated to boiling and held for about 10 minutes, cooled and acidified (ph 2- 3) using hydrochloric acid. The acidified mixture is concentrated by evaporation and then the isolated solid is extracted several times using warm ethanol. After combining the liquids and adjusting to a pH of 8-9 using a potassium hydroxide solution in ethanol, N-aminopiperidine is obtained.
  • the present invention is directed to a method of producing 1- aminopiperidine (also known as piperidine- 1-ylamine, N-aminopiperidine, N- piperidylamine, 1-piperidinamine and N,N-pentamethylenehydrazine or N 5 N- pentamethylenehydrazone) from piperidine.
  • 1- aminopiperidine also known as piperidine- 1-ylamine, N-aminopiperidine, N- piperidylamine, 1-piperidinamine and N,N-pentamethylenehydrazine or N 5 N- pentamethylenehydrazone
  • aqueous hydroxylamine-O- sulfonic (HOS) acid is added, such as in a stepwise fashion, to an aqueous; alkaline (caustic) solution of piperidine.
  • the HOS is added over about a 1 to 4 hour time period, preferably over about a 2 to 3 hour time period. While the HOS could be added in a continuous fashion over that period, it is suitable to add individual portions of HOS, for example in 2 to 5 different equal spaced apart portions over that time with stirring of the reaction mixture between the separate additions.
  • the cumulative mole ratio of the piperidine (P) to the aqueous hydroxylamine-O-sulfonic (HOS), i.e., P:HOS, is at least 2:1, preferably at least 2.5:1 and more preferably at least 3:1.
  • the P :HOS ratio will typically be below about 6:1, usually below about 5 : 1 and often below about 4:1.
  • a cumulative mole ratio of about 3 : 1 is particularly preferred.
  • the product 1-aminopiperidine is recovered as a solution in excess piperidine (organic phase) after several aqueous sodium hydroxide extractions.
  • HOS is freshly prepared in water. Five portions of HOS (each portion of 28.6 kg, i.e., 252 mol/portion) for a total amount of about 143 kg (260 mol) in water (57 kg per portion, total amount of 285 kg). [0009] A reactor is charged with sodium hydroxide (88 kg, 2210 mol) and water
  • a freshly prepared portion of Hydroxylamine-0-sulfonic acid, 113 kg is subdivided into three portions of about 38 kg each (i.e., 0.33 kmol/portion). Each portion is individually added to a previously prepared concentrated aqueous alkaline solution of piperidine (piperidine 272 kg (3.20 kmol), sodium hydroxide 128 kg (3.20 kmol) and water 36 kg (1.99 kmol)).
  • the alkaline piperidine solution is maintained at a temperature of about 55 ⁇ 5 0 C during the HOS addition.
  • the mixture is stirred at a temperature of about 55 ⁇ 5 0 C for about 15 ⁇ 5 minutes.
  • the reactor is emptied and the liquid is pumped back into the reactor at a temperature of about 50 + 5 °C.
  • the aqueous and organic phases are separated at 50 + 5 Q C and the lower aqueous phase is removed.
  • the upper organic phase contains the desired 1-amino ⁇ iperidine product and is kept at 50 ⁇ 5 °C for processing.
  • the lower water phase is discarded.
  • Sodium hydroxide 48 kg (1.20 kmol) is added to the organic phase at a temperature of 50 ⁇ 5 0 C and stirred for 20 min. Any undissolved sodium hydroxyde is filtered off at 50 ⁇ 5 0 C, and the aqueous and organic phases which form are separated at 50 ⁇ 5 0 C. Again, the lower aqueous phase is removed.
  • the resulting piperidine solution typically will contain about 20-25 % by weight of the 1-aminopiperidine. If desired, the 1 -aminopiperidine can be recovered from the piperidine solution using known techniques.
  • the initial addition of HOS to the aqueous alkaline piperidine solution and the initial reaction between the HOS and piperidine is preferably conducted at an elevated temperature ⁇ i.e., above room temperature), such as between 25 and 70 0 C.
  • an elevated temperature ⁇ i.e., above room temperature
  • Such initial addition and initial reaction is more usually conducted at a temperature between 30 and 60 0 C, and generally at a temperature of between 35 and 45 0 C.
  • the initial aqueous alkaline piperidine contains piperidine at a concentration of at least one mole of piperidine per mole of water and preferably at least about 1.5 mole of piperidine per mole of water. While it may be possible to conduct the reaction in other polar solvents, water is preferred,
  • the piperidine is added to an aqueous alkaline solution to establish the initial reaction mixture.
  • potassium hydroxide can be used for preparing the aqueous alkaline solution, it is preferred to use sodium hydroxide.
  • the reaction mixture will preferably contain from about 50% of saturation up to a substantially saturated solution of base, e.g., sodium hydroxide.
  • base e.g., sodium hydroxide.
  • base e.g., sodium hydroxide
  • Methods of preparing HOS are well known and need not be described in detail. For example, HOS can be prepared by the reaction of hydroxylamine sulfate with chlorosulfonic acid.
  • the invention constitutes the preparation of 1- aminopiperidine by reaction between piperidine and HOS at a cumulative mole ratio of piperidine (P) to the aqueous hydroxylamine-O-sulfonic (HOS), i.e., P:HOS, of at least 2:1, preferably at least 2.5:1 and more preferably at least 3:1, but below about 6:1, usually below about 5: 1 and often below about 4:1.
  • a cumulative mole ratio of about 3:1 is particularly preferred.
  • the invention constitutes the preparation of 1 - amiaopiperidine by reaction between piperidine and HOS by the slow addition of HOS to a concentrated aqueous alkaline solution of piperidine.
  • the HOS preferably is added to the concentrated aqueous alkaline solution containing piperidine over about a 1 to 4 hour time period, preferably over about a 2 to 3 hour time period.
  • the HOS can be added to the piperidine in a continuous fashion over that period, it is suitable, if not desirable to add separate individual portions of HOS to the piperidine. For example, from 2 to 5 separate but equal spaced apart portions of the HOS reagent can be added individually to the concentrated aqueous alkaline piperidine over the above-noted time period with stirring of the reaction mixture between the separate additions.
  • the invention constitutes the preparation of 1- aminopiperidine by reaction between piperidine and HOS by the slow addition of HOS to a concentrated aqueous alkaline solution of piperidine at an elevated temperature (i.e., above room temperature), such as between 25 and 70 0 C.
  • the initial addition of the HOS and the initial reaction between HOS and piperidine is more usually conducted at a temperature between 30 and 60 0 C, and generally at a temperature of between 35 and 45 0 C.
  • the product is worked up by a series of alkaline extractions, preferably using the same base used for preparing the initial reaction solution.
  • Sodium hydroxide is preferred.
  • the alkaline extractions are typically conducted at a temperature between 40 and 70 0 C, more usually at a temperature between 45 and 60 0 C, and most often about 55 0 C.
  • Final product recovery is conducted by isolating and cooling the organic piperidine phase to a temperature below about 10 0 C, and typically in the range of 0 to 7 0 C, for a time sufficient to precipitate any residual base, e.g., sodium hydroxide, and other solid impurities. Usually a time period of about 1 to about 5 hours should be sufficient.
  • the 1-aminopiperidine is recovered in excess piperidine. Further processing of the piperidine solution does not form a part of the present invention.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

This invention relates to a method for synthesizing 1 -amino piperidine (N- aminopiperidine) which selects a proper molar ratio of the starting materials, preferably a cumulative mole ratio of piperidine to the aqueous hydroxylamine-O-sulfonic of at least 2: 1, and closely regulates the reaction temperature and the method of product isolation to achieve a high product conversion.

Description

Synthesis of 1-Aminopiperidine
BACKGROUND OF THE INVENTION
Field of the Invention
[0001 ] This invention broadly relates to a method for synthesizing 1-amino piperidine (N-aminoρiρeridine). By selecting a proper molar ratio of the starting materials and closely regulating the reaction temperature and the method of product isolation, a high product conversion has been achieved.
Description of Related Art
[0002] German Patent 338608 describes reacting piperidine (P) with hydroxylamine-0-sulfonic (HOS) acid in an aqueous alkaline solution (potassium hydroxide) at a mole ratio of P:HOS of about 1.5:1. The HOS was added at a temperature of about 50-700C over a period of about 30 minutes. Thereafter, the reaction mixture was heated to boiling and held for about 10 minutes, cooled and acidified (ph 2- 3) using hydrochloric acid. The acidified mixture is concentrated by evaporation and then the isolated solid is extracted several times using warm ethanol. After combining the liquids and adjusting to a pH of 8-9 using a potassium hydroxide solution in ethanol, N-aminopiperidine is obtained.
[0003] More efficient ways of producing 1-arninopiperidine is of value to the pharmaceutical arts as it constitutes an important raw material.
SUMMARY OF THE INVENTION
[0004] The present invention is directed to a method of producing 1- aminopiperidine (also known as piperidine- 1-ylamine, N-aminopiperidine, N- piperidylamine, 1-piperidinamine and N,N-pentamethylenehydrazine or N5N- pentamethylenehydrazone) from piperidine. [0005] The present invention is based on the following reaction between piperidine (P) with hydroxylamine-O-sulfonic acid (HOS):
Figure imgf000003_0001
[0006] According to the method, freshly prepared, aqueous hydroxylamine-O- sulfonic (HOS) acid is added, such as in a stepwise fashion, to an aqueous; alkaline (caustic) solution of piperidine. The HOS is added over about a 1 to 4 hour time period, preferably over about a 2 to 3 hour time period. While the HOS could be added in a continuous fashion over that period, it is suitable to add individual portions of HOS, for example in 2 to 5 different equal spaced apart portions over that time with stirring of the reaction mixture between the separate additions.
[0007] The cumulative mole ratio of the piperidine (P) to the aqueous hydroxylamine-O-sulfonic (HOS), i.e., P:HOS, is at least 2:1, preferably at least 2.5:1 and more preferably at least 3:1. The P :HOS ratio will typically be below about 6:1, usually below about 5 : 1 and often below about 4:1. A cumulative mole ratio of about 3 : 1 is particularly preferred. The product 1-aminopiperidine is recovered as a solution in excess piperidine (organic phase) after several aqueous sodium hydroxide extractions.
DETAILED DESCRIPTION OF THE INVENTION
[0008] In one embodiment of the invention, hydroxylamine-O-sulfonic acid
(HOS) is freshly prepared in water. Five portions of HOS (each portion of 28.6 kg, i.e., 252 mol/portion) for a total amount of about 143 kg (260 mol) in water (57 kg per portion, total amount of 285 kg). [0009] A reactor is charged with sodium hydroxide (88 kg, 2210 mol) and water
(48 kg, 2650 mol) and then heated to a temperature of 65±5 0C to dissolve the sodium hydroxide completely. The sodium hydroxide solution then is cooled to a temperature of 55±50C and piperidine (327 kg, 3850 mol) is added. The solution is stirred at a temperature of 55 + 5 0C for 15 min to ensure complete dissolution and then cooled to a temperature of about 40±5°C.
[0010] The five separate portions of the aqueous hydroxylamine-O-sulfonic acid, described above, is added into the reaction mixture at a temperature of 55±5°C over a period of 180±60 min. After the addition of the last portion of HOS, the mixture is stirred at 55±5°C for an additional time period of 15±5 min.
[0011] At this point additional sodium hydroxide in an amount of 87 kg (2175 mol) is added and the mixture is stirred at 55±5 0C for an additional time period of 30±10 min. The contents of the reactor then is emptied and the liquid is pumped back into the reactor at a temperature of 55±5°C.
[0012] Thereafter, four additional charges of sodium hydroxide are made over time in an amount respectively of 43, 21, 21, 21 kg. The reaction mixture is maintained at a temperature of about 55±5°C as these portions of sodium hydroxide are separately added. Before each additional portion of sodium hydroxide is added, the previous addition of sodium hydroxide should be totally dissolved. This may require about 5 to 10 min of stirring before the next portion is added. Once all of the sodium hydroxide has been added and thoroughly mixed, the organic and aqueous phases are allowed to separate. The lower aqueous phase is removed and can be discarded.
[0013] Another (fifth) charge of sodium hydroxide (21 kg) then is added at a temperature of about 55±5°C and stirred for about 20 min. Any undissolved sodium hydroxide is filtered off at 55±5°C and the phases are allowed once again to separate. As before, the lower water phase is removed and discarded. [0014] The recovered organic phase then is cooled to a temperature of about 0 to
70C and stirred slowly for a time period of 4±1 hours. Any precipitates that form are filtered off and the liquid containing the desired 1-aminopiperidine is recovered.
[0015] In accordance with another embodiment of the invention, a freshly prepared portion of Hydroxylamine-0-sulfonic acid, 113 kg, is subdivided into three portions of about 38 kg each (i.e., 0.33 kmol/portion). Each portion is individually added to a previously prepared concentrated aqueous alkaline solution of piperidine (piperidine 272 kg (3.20 kmol), sodium hydroxide 128 kg (3.20 kmol) and water 36 kg (1.99 kmol)). The alkaline piperidine solution is maintained at a temperature of about 55 ± 5 0C during the HOS addition. After the addition of all three portions is completed, the mixture is stirred at a temperature of about 55 ± 5 0C for about 15 ± 5 minutes.
[0016] After completing the reaction, the reactor is emptied and the liquid is pumped back into the reactor at a temperature of about 50 + 5 °C. The aqueous and organic phases are separated at 50 + 5 QC and the lower aqueous phase is removed. The upper organic phase contains the desired 1-aminoρiperidine product and is kept at 50 ± 5 °C for processing. The lower water phase is discarded.
[0017] Sodium hydroxide 48 kg (1.20 kmol) is added to the organic phase at a temperature of 50 ± 5 0C and stirred for 20 min. Any undissolved sodium hydroxyde is filtered off at 50 ± 5 0C, and the aqueous and organic phases which form are separated at 50 ± 5 0C. Again, the lower aqueous phase is removed.
[0018] Another portion of sodium hydroxide 22 kg (0.55 kmol) is added to the organic phase at a temperature of about 50 ± 5 0C and stirred for 20 min. Any undissolved sodium hydroxyde is filtered off at a temperature of 50 ± 5 0C, and the phases are allowed to separate at a temperature of 50 ± 5 0C. Once again, the lower aqueous phase is removed and discarded. [0019] At this point, the organic phase is cooled to a temperature of about 5 +2
0C and stirred slowly. During this time, solid impurities and sodium hydroxide precipitates form and they are filtered off at a temperature of 5+ 2 0C. The remaining organic liquid phase contains the desired N-Aminopiperidine in unreacted piperidine and is recovered as the product.
[0020] When practicing the present invention, the resulting piperidine solution typically will contain about 20-25 % by weight of the 1-aminopiperidine. If desired, the 1 -aminopiperidine can be recovered from the piperidine solution using known techniques.
[0021] The initial addition of HOS to the aqueous alkaline piperidine solution and the initial reaction between the HOS and piperidine is preferably conducted at an elevated temperature {i.e., above room temperature), such as between 25 and 70 0C. Such initial addition and initial reaction is more usually conducted at a temperature between 30 and 60 0C, and generally at a temperature of between 35 and 45 0C.
[0022] Preferably, the initial aqueous alkaline piperidine contains piperidine at a concentration of at least one mole of piperidine per mole of water and preferably at least about 1.5 mole of piperidine per mole of water. While it may be possible to conduct the reaction in other polar solvents, water is preferred,
[0023] Preferably, the piperidine is added to an aqueous alkaline solution to establish the initial reaction mixture. While potassium hydroxide can be used for preparing the aqueous alkaline solution, it is preferred to use sodium hydroxide. Generally the same base will be used both for initially preparing the reaction solution and for the subsequent product work-up. The reaction mixture will preferably contain from about 50% of saturation up to a substantially saturated solution of base, e.g., sodium hydroxide. Thus, about 0.5 to 1.0 mole of base, e.g., sodium hydroxide, per mole of piperidine is present in the initial reaction mixture solution. [0024] Methods of preparing HOS are well known and need not be described in detail. For example, HOS can be prepared by the reaction of hydroxylamine sulfate with chlorosulfonic acid.
[0025] In one aspect, the invention constitutes the preparation of 1- aminopiperidine by reaction between piperidine and HOS at a cumulative mole ratio of piperidine (P) to the aqueous hydroxylamine-O-sulfonic (HOS), i.e., P:HOS, of at least 2:1, preferably at least 2.5:1 and more preferably at least 3:1, but below about 6:1, usually below about 5: 1 and often below about 4:1. As noted above, a cumulative mole ratio of about 3:1 is particularly preferred.
[0026] In another aspect, the invention constitutes the preparation of 1 - amiaopiperidine by reaction between piperidine and HOS by the slow addition of HOS to a concentrated aqueous alkaline solution of piperidine. The HOS preferably is added to the concentrated aqueous alkaline solution containing piperidine over about a 1 to 4 hour time period, preferably over about a 2 to 3 hour time period. While the HOS can be added to the piperidine in a continuous fashion over that period, it is suitable, if not desirable to add separate individual portions of HOS to the piperidine. For example, from 2 to 5 separate but equal spaced apart portions of the HOS reagent can be added individually to the concentrated aqueous alkaline piperidine over the above-noted time period with stirring of the reaction mixture between the separate additions.
[0027} In. still another aspect, the invention constitutes the preparation of 1- aminopiperidine by reaction between piperidine and HOS by the slow addition of HOS to a concentrated aqueous alkaline solution of piperidine at an elevated temperature (i.e., above room temperature), such as between 25 and 700C. The initial addition of the HOS and the initial reaction between HOS and piperidine is more usually conducted at a temperature between 30 and 600C, and generally at a temperature of between 35 and 45 0C.
[0028] In yet another aspect of the present invention, the product is worked up by a series of alkaline extractions, preferably using the same base used for preparing the initial reaction solution. Sodium hydroxide is preferred. The alkaline extractions are typically conducted at a temperature between 40 and 700C, more usually at a temperature between 45 and 600C, and most often about 55 0C.
[0029] Final product recovery is conducted by isolating and cooling the organic piperidine phase to a temperature below about 100C, and typically in the range of 0 to 7 0C, for a time sufficient to precipitate any residual base, e.g., sodium hydroxide, and other solid impurities. Usually a time period of about 1 to about 5 hours should be sufficient. The 1-aminopiperidine is recovered in excess piperidine. Further processing of the piperidine solution does not form a part of the present invention.
[0030] The present invention has been described with reference to specific embodiments. However, this application is intended to cover those changes and substitutions that may be made by those skilled in the art without departing from the spirit and the scope of the invention. Unless otherwise specifically indicated, all percentages are by weight. Also, unless to context shows otherwise, the term "about" is intended to encompass + or - 5% throughout the specification.

Claims

Claims
1. A method of producing 1 -aminopiperidine from piperidine and hydroxylamine-O-sulfonic acid by adding aqueous hydroxylamine-O-sulfonic acid to an aqueous alkaline solution of piperidine to provide a cumulative mole ratio of the piperidine to the aqueous hydroxylamine-O-sulfonic of at least 2:1.
2. The method of claim 1 wherein the aqueous hydroxylamine-O-sulfonic acid is freshly prepared when added to the piperidine.
3. The method of claim 1 or 2, wherein the hydroxylamine-O-sulfonic acid is added to the aqueous alkaline solution of piperidine over a time period of 1 to 4 hours.
4. The method of claim 3 wherein the time period is 2 to 3 hours.
5. The method of claim 1 or 2 wherein the hydroxylamine-O-sulfonic acid is stepwise added to the aqueous alkaline solution of piperidine.
6. The method of claim 3 wherein the hydroxylamine-O-sulfonic acid is stepwise added to the aqueous alkaline solution of piperidine.
7. The method of claim 5 wherein the hydroxylamine-O-sulfonic acid is added to the aqueous alkaline solution of piperidine in 2 to five different portions.
8. The method of claim 1 or 2 wherein the cumulative mole ratio is at least 2.5:1.
9. The method of claim 1 or 2 wherein the cumulative mole ratio is at least 3:1.
10. The method of claim 1 or 2 wherein the cumulative mole ratio is below 6:1.
11. The method of claim 8 wherein the cumulative mole ratio is below 5:1.
12. The method of claim 9 wherein the cumulative mole ratio is below 4:1.
13. The method of claim 1 or 2 wherein 1-aminopiperidine recovered in excess piperidine is treated with sodium hydroxide, resulting organic and aqueous phases are separated and the organic phase is cooled to a temperature below 1O 0C.
14. The method of claim 1 or 2 wherein an organic phase of 1-aminopiperidine recovered in excess piperidine is separated from an aqueous phase, the organic phase is treated with sodium hydroxide, resulting organic and aqueous phases are separated and the organic phase is cooled to a temperature below 10 0C.
15. The method of claim 13 wherein the cooled organic phase is filtered to produce 1-aminopiperidine in solution with piperidine.
16. The method of claim 14 wherein the cooled organic phase is filtered to produce 1-aminopiperidine in solution with piperidine.
17. The method of claim 1 or 2 wherein the aqueous hydroxylamine-O-sulfonic acid is added to the aqueous alkaline solution of piperidine at a temperature of 25 0C and 700C.
PCT/SE2006/000499 2005-04-26 2006-04-26 Synthesis of 1-aminopiperidine Ceased WO2006115456A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67467905P 2005-04-26 2005-04-26
US60/674,679 2005-04-26

Publications (1)

Publication Number Publication Date
WO2006115456A1 true WO2006115456A1 (en) 2006-11-02

Family

ID=37215010

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE2006/000499 Ceased WO2006115456A1 (en) 2005-04-26 2006-04-26 Synthesis of 1-aminopiperidine

Country Status (1)

Country Link
WO (1) WO2006115456A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010142810A1 (en) * 2009-06-12 2010-12-16 Centre National De La Recherche Scientifique (Cnrs) Synthesis of hydrazines from hydroxylamine-o-sulphonic acid

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE338609C (en) * 1919-10-15 1921-06-22 Fritz Sommer Dr Process for the preparation of hydrazine and its alkyl or aryl substitution products
GB866681A (en) * 1958-05-22 1961-04-26 May & Baker Ltd N-substituted piperidines
US3583979A (en) * 1969-05-06 1971-06-08 Upjohn Co Process for preparing n-aminohexamethyleneimine
EP0230895A2 (en) * 1986-01-17 1987-08-05 BASF Aktiengesellschaft Process for producing hydroxylamine-0-sulfonic acid
EP0249452A1 (en) * 1986-06-13 1987-12-16 Ube Industries, Ltd. Process for producing N-aminohexamethyleneimine
WO2005035496A1 (en) * 2003-10-03 2005-04-21 Aventis Pharmaceuticals Inc. Process for the preparation of n-amino substituted heterocyclic compounds

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE338609C (en) * 1919-10-15 1921-06-22 Fritz Sommer Dr Process for the preparation of hydrazine and its alkyl or aryl substitution products
GB866681A (en) * 1958-05-22 1961-04-26 May & Baker Ltd N-substituted piperidines
US3583979A (en) * 1969-05-06 1971-06-08 Upjohn Co Process for preparing n-aminohexamethyleneimine
EP0230895A2 (en) * 1986-01-17 1987-08-05 BASF Aktiengesellschaft Process for producing hydroxylamine-0-sulfonic acid
EP0249452A1 (en) * 1986-06-13 1987-12-16 Ube Industries, Ltd. Process for producing N-aminohexamethyleneimine
WO2005035496A1 (en) * 2003-10-03 2005-04-21 Aventis Pharmaceuticals Inc. Process for the preparation of n-amino substituted heterocyclic compounds

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GÖSL R.: "Synthesis of substituted hydrazones from amines with hydroxylamino-O-sulfonic acid", CHEMISCHE BERICHTE, vol. 92, 1959, pages 2521 - 2531, XP003001381 *
SOMEI M. ET AL.: "A novel N-amination method and its application to the preparation of N-aminoheterocycles", CHEMICAL & PHARMACEUTICAL BULLETIN, vol. 26, no. 8, 1978, pages 2522 - 2534, XP003001382 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010142810A1 (en) * 2009-06-12 2010-12-16 Centre National De La Recherche Scientifique (Cnrs) Synthesis of hydrazines from hydroxylamine-o-sulphonic acid
FR2946651A1 (en) * 2009-06-12 2010-12-17 Centre Nat Rech Scient SYNTHESIS OF HYDRAZINES FROM HYDROXYLAMINE-O-SULFONIC ACID.

Similar Documents

Publication Publication Date Title
CN105753888A (en) Preparation method for free-state edoxaban
US20070066831A1 (en) Process for the preparation of letrozole
NO150668B (en) PROCEDURE FOR THE PREPARATION OF A MONOLITIC MACHINE PART WITH PARTS OF DIFFERENT ALLOY COMPOSITION BY POWDER METAL SURGERY
CN103459392B (en) A kind of method for preparing pemetrexed salt
EP3237379B1 (en) Process for preparing alpha-carboxamide pyrrolidine derivatives
CN105859589B (en) A method of preparing bambuterol impurity C
CN102863359A (en) Synthesis method of anti-flu medicine
JP2005511668A (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and process for their preparation
WO2006115456A1 (en) Synthesis of 1-aminopiperidine
CN100402509C (en) A kind of synthetic method of 4,4-dimethylisoxazol-3-ketone
CN105085510B (en) A kind of preparation method of the carboxylic acid tert-butyl ester of (S) 4 oxo 2 (carbonyl of thiazolidine 3) pyrrolidines 1
CN108164423B (en) Preparation method of naftifine hydrochloride
CN110156636A (en) A kind of preparation method of N- nitroso iminodiacetonitrile
CN110105310A (en) A kind of method of continuous preparation (2R, 3R) -2,3- epoxy butyric acid
CN103214395A (en) Synthesizing process of 2,3-dicyanoethylpropionate
CN108314674A (en) A kind of Ai Li replaces the preparation method of Buddhist nun's intermediate
US6583293B1 (en) Preparation method of 3-nitro-1,2,4-triazol-5-one by a process minimizing heat generation during crystallization
KR100829894B1 (en) Method for preparing dimacrotic acid and its magnesium salt
CN109438310A (en) A kind of vitamin D 3-derivatives and preparation method thereof
WO2013075732A1 (en) Process for making crystalline form i of etoricoxib
JP2567394B2 (en) Process for producing 6-N-benzylamino-9-benzylpurines
EP0131472A2 (en) 5-Mercapto-1,2,3-thiadiazoles composition and process for preparing the same
CN112094198B (en) A method for synthesizing N-nitroso-N-methyl-4-aminobutyric acid
JPH0629273B2 (en) Process for producing N-aminohexamethyleneimine
CN107840823A (en) For the method for the scalable for preparing Sorafenib Tosylate alcohol solvent compound and III type Sorafenib Tosylates

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06733355

Country of ref document: EP

Kind code of ref document: A1